SyriMed previously known as Thame Laboratories Licensed Medicines Division is one of the leading Pharmaceutical Companies in the UK specialising in the development, licensing, manufacture and marketing of liquid medicines.
Established during 2004 in Ruislip, West London; SyriMed with the experience from the development and manufacture of unlicensed medicines started in 2014 to obtain marketing authorisations for its unlicensed liquid medicines. In May 2020, SyriMed held over 50 marketing authorisations for liquid medicines within the UK.
SyriMed’s success stems from its vibrant and productive Research and Development Department which develops and manufactures formulations for licensed medicines . All of SyriMed’s formulations for which it holds marketing authorisations have been developed by SyriMed’s own scientists.
SyriMed manufactures licensed medicines in its own facilities that meet the quality requirements of EU Good Manufacturing Practice (GMP).
Our in-house laboratories test the medicines manufactured to ensure they meet the strict requirements set by regulatory authorities.